Literature DB >> 3713109

Hypothesis: selective ineffective humoral immune responsiveness as a possible cause of certain chronic inflammatory disorders. Theoretical considerations and rationale for treatment.

A Hässig, H Cottier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3713109     DOI： 10.1007/bf01727524

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  28 in total

1.  [Therapy of herpes zoster with human globulin].

Authors:  H GROS
Journal:  Dtsch Med Wochenschr       Date:  1952-09-05       Impact factor: 0.628

2.  Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

Authors:  Y Sultan; M D Kazatchkine; P Maisonneuve; U E Nydegger
Journal:  Lancet       Date:  1984-10-06       Impact factor: 79.321

Review 3.  Antiviral therapy. Varicella-zoster virus infections, herpes labialis and mucocutaneous herpes, and cytomegalovirus infections.

Authors:  K G Nicholson
Journal:  Lancet       Date:  1984-09-22       Impact factor: 79.321

4.  Clusters of HLA class II beta restriction fragments describe allelic series.

Authors:  D Cohen; I Le Gall; A Marcadet; M P Font; J M Lalouel; J Dausset
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

5.  T cell antigen receptors and the immunoglobulin supergene family.

Authors:  L Hood; M Kronenberg; T Hunkapiller
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

Review 6.  Genetics of the major histocompatibility complex: the final act.

Authors:  J Klein; F Figueroa; Z A Nagy
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

7.  Nonspecific immune modulating effects of ascites fluid and hyperimmune sera in vivo.

Authors:  F Nagase; N M Ponzio; C Waltenbaugh; I Katz; G J Thorbecke
Journal:  Cell Immunol       Date:  1985-01       Impact factor: 4.868

8.  Intravenous immunoglobulin therapy for antibody deficiency.

Authors:  M T Nolte; B Pirofsky; G A Gerritz; B Golding
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

9.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

Review 10.  Complement, viruses, and virus-infected cells.

Authors:  N R Cooper; G R Nemerow
Journal:  Springer Semin Immunopathol       Date:  1983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.